Melting point	10 ºC
Water Solubility	soluble
Boiling point	113 ºC
Density	1.27

Symbol(GHS)	C
Hazard Codes	R22;R34
SDS/MSDS	S26;S36/37/39;S45

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

8-Amino-adenosine inhibits multiple mechanisms of transcription.Jennifer Ann Frey et al.Molecular cancer therapeutics, 9(1), 236-245 (2010-01-08) Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.Mala Shanmugam et al.The Journal of biological chemistry, 284(39), 26816-26830 (2009-08-04) Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms.Samuel K McBrayer et al.PloS one, 7(7), e41455-e41455 (2012-08-01) Binding isotherms of nucleosides and polynucleotides measured by continuous ultrafiltration at constant volume: a rapid and precise technique.K B Roy et al.Biochemistry, 21(1), 57-62 (1982-01-05) Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine.Kumudha Balakrishnan et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 11(18), 6745-6752 (2005-09-17) 8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma.Kulsoom Ghias et al.Molecular cancer therapeutics, 4(4), 569-577 (2005-04-14) Property editing of peptide nucleic acids (PNA): gem-dimethyl, cyanuryl and 8-aminoadenine PNAs.Krishna N Ganesh et al.Nucleic acids symposium series (2004), (51)(51), 17-18 (2007-11-22) 8-amino-adenosine is a potential therapeutic agent for multiple myeloma.Nancy L Krett et al.Molecular cancer therapeutics, 3(11), 1411-1420 (2004-11-16) Non-tyrosine kinase inhibitor-targeting of BCR-ABL expressing cells.Olga Frankfurt et al.Leukemia & lymphoma, 53(10), 1857-1858 (2012-05-10) Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.Rathi N Pillai et al.Leukemia & lymphoma, 53(10), 2024-2032 (2012-03-28)

Remarks